Products

nextmillionai

Uses AISkill

The open source alternative to YC's Paxel.

nextmillionai.org SourceSoftware Development / Developer Utilities

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
anshuli gupta
@anshulix· 747 followers
Launched
Unknown
No public launch record

Traffic

Last 12 months
Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions

No launch, search, referral, or promotion moves recorded for this product yet.

Open Source & Agent Ecosystem

GitHub · MCP / Skill
GitHub Stars
Public repo
Forks
—
License
See repository
Primary language
—

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered Unknown

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-09 · Source page

Pages & changes

Tracked since 2026-11-06

Key pages

Weekly snapshots
nextmillionai.org/story/ Snapshot 2026-11-10

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does nextmillionai get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is nextmillionai and what platforms does it support?
nextmillionai is catalogued under Developer Utilities: The open source alternative to YC's Paxel.. Supported platforms: CLI / SDK.
Is nextmillionai open source?
nextmillionai has a public repository (https://github.com/nextmillionai/nextmillionai) with its source repository published.Source

Related products in this category

Software Development / Developer Utilities

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.